1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Strontium-89: new trials by email Literature Review of Strontium-89 trials Research Report on Strontium-89
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases Celecoxib, Doxorubicin Hydrochloride, Strontium chloride Sr 89 - Metastatic Cancer, Prostate Cancer | Phase 2 | Terminated | M.D. Anderson Cancer Center | 14 | 2002-02-01 | 2018-10-31 |
Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
M.D. Anderson Cancer Center (1)
United States (1)
Shi-Ming Tu, MD (1)
P30CA016672 (1), P50CA090270 (1)